Chris Harryman1, Margaret A Plymale2, Evan Stearns1, Daniel L Davenport3, Wayne Chang4, J Scott Roth4. 1. College of Medicine, University of Kentucky, Lexington, USA. 2. Department of Surgery, Division of General Surgery, University of Kentucky, C 241, Chandler Medical Center, 800 Rose Street, Lexington, KY, 40536, USA. mplym0@uky.edu. 3. Department of Surgery, University of Kentucky, Lexington, USA. 4. Department of Surgery, Division of General Surgery, University of Kentucky, C 241, Chandler Medical Center, 800 Rose Street, Lexington, KY, 40536, USA.
Abstract
BACKGROUND: Open ventral hernia repair (VHR) is associated with postoperative complications and hospital readmissions. A comprehensive Enhanced Recovery after Surgery (ERAS) protocol for VHR contributes to improved clinical outcomes including the rapid return of bowel function and reduced infections. The purpose of this study was to compare hospital costs for patients cared for prior to ERAS implementation with patients cared for with an ERAS protocol. METHODS: With IRB approval, clinical characteristics and postoperative outcomes data were obtained via retrospective review of consecutive VHR patients 2 years prior to and 14 months post ERAS implementation. Hospital cost data were obtained from the cost accounting system inclusive of index hospitalization. Clinical data and hospital costs were compared between groups. RESULTS: Data for 178 patients (127 pre-ERAS, 51 post-ERAS) were analyzed. Preoperative and operative characteristics including gender, ASA class, comorbidities, and BMI were similar between groups. ERAS patients had faster return of bowel function (p = 0.001) and decreased incidence of superficial surgical site infection (p = 0.003). Hospital length of stay did not vary significantly pre and post ERAS implementation. Inpatient pharmacy costs were increased in ERAS group ($2673 vs. $1176 p < 0.001), but total hospital costs (14,692 vs. 15,151, p = 0.538) were similar between groups. CONCLUSIONS: Standardization of hernia care via ERAS protocol improves clinical outcomes without impacting total costs.
BACKGROUND: Open ventral hernia repair (VHR) is associated with postoperative complications and hospital readmissions. A comprehensive Enhanced Recovery after Surgery (ERAS) protocol for VHR contributes to improved clinical outcomes including the rapid return of bowel function and reduced infections. The purpose of this study was to compare hospital costs for patients cared for prior to ERAS implementation with patients cared for with an ERAS protocol. METHODS: With IRB approval, clinical characteristics and postoperative outcomes data were obtained via retrospective review of consecutive VHR patients 2 years prior to and 14 months post ERAS implementation. Hospital cost data were obtained from the cost accounting system inclusive of index hospitalization. Clinical data and hospital costs were compared between groups. RESULTS: Data for 178 patients (127 pre-ERAS, 51 post-ERAS) were analyzed. Preoperative and operative characteristics including gender, ASA class, comorbidities, and BMI were similar between groups. ERAS patients had faster return of bowel function (p = 0.001) and decreased incidence of superficial surgical site infection (p = 0.003). Hospital length of stay did not vary significantly pre and post ERAS implementation. Inpatient pharmacy costs were increased in ERAS group ($2673 vs. $1176 p < 0.001), but total hospital costs (14,692 vs. 15,151, p = 0.538) were similar between groups. CONCLUSIONS: Standardization of hernia care via ERAS protocol improves clinical outcomes without impacting total costs.
Authors: A Sartori; E Botteri; F Agresta; C Gerardi; N Vettoretto; A Arezzo; A Pisanu; S Di Saverio; G Campanelli; M Podda Journal: Hernia Date: 2020-07-18 Impact factor: 4.739
Authors: S T Adams; N H Bedwani; L H Massey; A Bhargava; C Byrne; K K Jensen; N J Smart; C J Walsh Journal: Hernia Date: 2022-01-13 Impact factor: 2.920
Authors: Austin P Seaman; Kathryn A Schlosser; Daniel Eiferman; Vimal Narula; Benjamin K Poulose; Jeffrey E Janis Journal: J Gastrointest Surg Date: 2022-01-10 Impact factor: 3.267